Cargando…

Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species

INTRODUCTION: Risk factors for carbapenemase-producing Enterobacterales (CPE) acquisition/infection and associated clinical outcomes have been evaluated in the context of clonal, species-specific outbreaks. Equivalent analyses for complex, multi-species outbreaks, which are increasingly common, are...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathers, A.J., Vegesana, K., German-Mesner, I., Ainsworth, J., Pannone, A., Crook, D.W., Sifri, C.D., Sheppard, A., Stoesser, N., Peto, T., Walker, A.S., Eyre, D.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: W.B. Saunders For The Hospital Infection Society 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193892/
https://www.ncbi.nlm.nih.gov/pubmed/31931046
http://dx.doi.org/10.1016/j.jhin.2020.01.005
_version_ 1783528270372798464
author Mathers, A.J.
Vegesana, K.
German-Mesner, I.
Ainsworth, J.
Pannone, A.
Crook, D.W.
Sifri, C.D.
Sheppard, A.
Stoesser, N.
Peto, T.
Walker, A.S.
Eyre, D.W.
author_facet Mathers, A.J.
Vegesana, K.
German-Mesner, I.
Ainsworth, J.
Pannone, A.
Crook, D.W.
Sifri, C.D.
Sheppard, A.
Stoesser, N.
Peto, T.
Walker, A.S.
Eyre, D.W.
author_sort Mathers, A.J.
collection PubMed
description INTRODUCTION: Risk factors for carbapenemase-producing Enterobacterales (CPE) acquisition/infection and associated clinical outcomes have been evaluated in the context of clonal, species-specific outbreaks. Equivalent analyses for complex, multi-species outbreaks, which are increasingly common, are lacking. METHODS: Between December 2010 and January 2017, a case–control study of Klebsiella pneumoniae carbapenemase (KPC)-producing organism (KPCO) acquisition was undertaken using electronic health records from inpatients in a US academic medical centre and long-term acute care hospital (LTACH) with ongoing multi-species KPCO transmission despite a robust CPE screening programme. Cases had a first KPCO-positive culture >48 h after admission, and included colonizations and infections (defined by clinical records). Controls had at least two negative perirectal screens and no positive cultures. Risk factors for KPCO acquisition, first infection following acquisition, and 14-day mortality following each episode of infection were identified using multi-variable logistic regression. RESULTS: In 303 cases (89 with at least one infection) and 5929 controls, risk factors for KPCO acquisition included: longer inpatient stay, transfusion, complex thoracic pathology, mechanical ventilation, dialysis, and exposure to carbapenems and β-lactam/β-lactamase inhibitors. Exposure to other KPCO-colonized patients was only a risk factor for acquisition in a single unit, suggesting that direct patient-to-patient transmission did not play a major role. There were 15 species of KPCO; 61 (20%) cases were colonized/infected with more than one species. Fourteen-day mortality following non-urinary KPCO infection was 20% (20/97 episodes) and was associated with failure to achieve source control. CONCLUSIONS: Healthcare exposures, antimicrobials and invasive procedures increased the risk of KPCO colonization/infection, suggesting potential targets for infection control interventions in multi-species outbreaks. Evidence for patient-to-patient transmission was limited.
format Online
Article
Text
id pubmed-7193892
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher W.B. Saunders For The Hospital Infection Society
record_format MEDLINE/PubMed
spelling pubmed-71938922020-05-05 Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species Mathers, A.J. Vegesana, K. German-Mesner, I. Ainsworth, J. Pannone, A. Crook, D.W. Sifri, C.D. Sheppard, A. Stoesser, N. Peto, T. Walker, A.S. Eyre, D.W. J Hosp Infect Article INTRODUCTION: Risk factors for carbapenemase-producing Enterobacterales (CPE) acquisition/infection and associated clinical outcomes have been evaluated in the context of clonal, species-specific outbreaks. Equivalent analyses for complex, multi-species outbreaks, which are increasingly common, are lacking. METHODS: Between December 2010 and January 2017, a case–control study of Klebsiella pneumoniae carbapenemase (KPC)-producing organism (KPCO) acquisition was undertaken using electronic health records from inpatients in a US academic medical centre and long-term acute care hospital (LTACH) with ongoing multi-species KPCO transmission despite a robust CPE screening programme. Cases had a first KPCO-positive culture >48 h after admission, and included colonizations and infections (defined by clinical records). Controls had at least two negative perirectal screens and no positive cultures. Risk factors for KPCO acquisition, first infection following acquisition, and 14-day mortality following each episode of infection were identified using multi-variable logistic regression. RESULTS: In 303 cases (89 with at least one infection) and 5929 controls, risk factors for KPCO acquisition included: longer inpatient stay, transfusion, complex thoracic pathology, mechanical ventilation, dialysis, and exposure to carbapenems and β-lactam/β-lactamase inhibitors. Exposure to other KPCO-colonized patients was only a risk factor for acquisition in a single unit, suggesting that direct patient-to-patient transmission did not play a major role. There were 15 species of KPCO; 61 (20%) cases were colonized/infected with more than one species. Fourteen-day mortality following non-urinary KPCO infection was 20% (20/97 episodes) and was associated with failure to achieve source control. CONCLUSIONS: Healthcare exposures, antimicrobials and invasive procedures increased the risk of KPCO colonization/infection, suggesting potential targets for infection control interventions in multi-species outbreaks. Evidence for patient-to-patient transmission was limited. W.B. Saunders For The Hospital Infection Society 2020-04 /pmc/articles/PMC7193892/ /pubmed/31931046 http://dx.doi.org/10.1016/j.jhin.2020.01.005 Text en Crown Copyright © 2020 Published by Elsevier Ltd on behalf of The Healthcare Infection Society. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mathers, A.J.
Vegesana, K.
German-Mesner, I.
Ainsworth, J.
Pannone, A.
Crook, D.W.
Sifri, C.D.
Sheppard, A.
Stoesser, N.
Peto, T.
Walker, A.S.
Eyre, D.W.
Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species
title Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species
title_full Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species
title_fullStr Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species
title_full_unstemmed Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species
title_short Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species
title_sort risk factors for klebsiella pneumoniae carbapenemase (kpc) gene acquisition and clinical outcomes across multiple bacterial species
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193892/
https://www.ncbi.nlm.nih.gov/pubmed/31931046
http://dx.doi.org/10.1016/j.jhin.2020.01.005
work_keys_str_mv AT mathersaj riskfactorsforklebsiellapneumoniaecarbapenemasekpcgeneacquisitionandclinicaloutcomesacrossmultiplebacterialspecies
AT vegesanak riskfactorsforklebsiellapneumoniaecarbapenemasekpcgeneacquisitionandclinicaloutcomesacrossmultiplebacterialspecies
AT germanmesneri riskfactorsforklebsiellapneumoniaecarbapenemasekpcgeneacquisitionandclinicaloutcomesacrossmultiplebacterialspecies
AT ainsworthj riskfactorsforklebsiellapneumoniaecarbapenemasekpcgeneacquisitionandclinicaloutcomesacrossmultiplebacterialspecies
AT pannonea riskfactorsforklebsiellapneumoniaecarbapenemasekpcgeneacquisitionandclinicaloutcomesacrossmultiplebacterialspecies
AT crookdw riskfactorsforklebsiellapneumoniaecarbapenemasekpcgeneacquisitionandclinicaloutcomesacrossmultiplebacterialspecies
AT sifricd riskfactorsforklebsiellapneumoniaecarbapenemasekpcgeneacquisitionandclinicaloutcomesacrossmultiplebacterialspecies
AT shepparda riskfactorsforklebsiellapneumoniaecarbapenemasekpcgeneacquisitionandclinicaloutcomesacrossmultiplebacterialspecies
AT stoessern riskfactorsforklebsiellapneumoniaecarbapenemasekpcgeneacquisitionandclinicaloutcomesacrossmultiplebacterialspecies
AT petot riskfactorsforklebsiellapneumoniaecarbapenemasekpcgeneacquisitionandclinicaloutcomesacrossmultiplebacterialspecies
AT walkeras riskfactorsforklebsiellapneumoniaecarbapenemasekpcgeneacquisitionandclinicaloutcomesacrossmultiplebacterialspecies
AT eyredw riskfactorsforklebsiellapneumoniaecarbapenemasekpcgeneacquisitionandclinicaloutcomesacrossmultiplebacterialspecies